» Articles » PMID: 24878760

The Effect of Tuning Cold Plasma Composition on Glioblastoma Cell Viability

Overview
Journal PLoS One
Date 2014 Jun 1
PMID 24878760
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Previous research in cold atmospheric plasma (CAP) and cancer cell interaction has repeatedly proven that the cold plasma induced cell death. It is postulated that the reactive oxygen species (ROS) and reactive nitrogen species (RNS) play a major role in the CAP cancer therapy. In this paper, we seek to determine a mechanism of CAP therapy on glioblastoma cells (U87) through an understanding of the composition of the plasma, including treatment time, voltage, flow-rate and plasma-gas composition. In order to determine the threshold of plasma treatment on U87, normal human astrocytes (E6/E7) were used as the comparison cell line. Our data showed that the 30 sec plasma treatment caused 3-fold cell death in the U87 cells compared to the E6/E7 cells. All the other compositions of cold plasma were performed based on this result: plasma treatment time was maintained at 30 s per well while other plasma characteristics such as voltage, flow rate of source gas, and composition of source gas were changed one at a time to vary the intensity of the reactive species composition in the plasma jet, which may finally have various effect on cells reflected by cell viability. We defined a term "plasma dosage" to summarize the relationship of all the characteristics and cell viability.

Citing Articles

Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrest.

Stoof J, Kalmoua Z, Sobota A, Brakenhoff R, Stigter M, Pham T Sci Rep. 2025; 15(1):2334.

PMID: 39824909 PMC: 11742390. DOI: 10.1038/s41598-025-85568-0.


Cold Physical Plasma Reduces Motility of Various Bone Sarcoma Cells While Remodeling the Cytoskeleton.

Nitsch A, Marthaler P, Qarqash S, Bemmann M, Bekeschus S, Wassilew G In Vivo. 2024; 38(4):1571-1578.

PMID: 38936915 PMC: 11215588. DOI: 10.21873/invivo.13607.


Skin treatment with non-thermal plasma modulates the immune system through miR-223-3p and its target genes.

Engel A, Ludwig N, Grandke F, Wagner V, Kern F, Fehlmann T RNA Biol. 2024; 21(1):31-44.

PMID: 38828710 PMC: 11152102. DOI: 10.1080/15476286.2024.2361571.


Comparing Redox and Intracellular Signalling Responses to Cold Plasma in Wound Healing and Cancer.

Abdo A, Kopecki Z Curr Issues Mol Biol. 2024; 46(5):4885-4923.

PMID: 38785562 PMC: 11120013. DOI: 10.3390/cimb46050294.


Comparative assessment of direct and indirect cold atmospheric plasma effects, based on helium and argon, on human glioblastoma: an in vitro and in vivo study.

Bakhtiyari-Ramezani M, Nohekhan M, Akbari M, Abbasvandi F, Bayat M, Akbari A Sci Rep. 2024; 14(1):3578.

PMID: 38347045 PMC: 10861458. DOI: 10.1038/s41598-024-54070-4.


References
1.
Walk R, Snyder J, Srinivasan P, Kirsch J, Diaz S, Blanco F . Cold atmospheric plasma for the ablative treatment of neuroblastoma. J Pediatr Surg. 2013; 48(1):67-73. DOI: 10.1016/j.jpedsurg.2012.10.020. View

2.
Brulle L, Vandamme M, Ries D, Martel E, Robert E, Lerondel S . Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model. PLoS One. 2013; 7(12):e52653. PMC: 3530450. DOI: 10.1371/journal.pone.0052653. View

3.
Beckman J, Koppenol W . Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996; 271(5 Pt 1):C1424-37. DOI: 10.1152/ajpcell.1996.271.5.C1424. View

4.
Johnson D, Patrick ONeill B . Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2011; 107(2):359-64. DOI: 10.1007/s11060-011-0749-4. View

5.
Yousfi M, Merbahi N, Pathak A, Eichwald O . Low-temperature plasmas at atmospheric pressure: toward new pharmaceutical treatments in medicine. Fundam Clin Pharmacol. 2013; 28(2):123-35. DOI: 10.1111/fcp.12018. View